INJECTABLE DEPOT COMPOSITIONS AND USES THEREOF
    82.
    发明公开
    INJECTABLE DEPOT COMPOSITIONS AND USES THEREOF 有权
    注射长效组合物及其

    公开(公告)号:EP1446100A2

    公开(公告)日:2004-08-18

    申请号:EP02793941.2

    申请日:2002-11-14

    申请人: ALZA CORPORATION

    IPC分类号: A61K9/00

    摘要: Injectable depot compositions are provided that include a bioerodible, biocompatible polymer, an aromatic alcohol having miscibility in water of less than or equal to 7 wt.% at 25°C, in an amount effective to plasticize the polymer and form a gel therewith, and a beneficial agent. The composition may additionally contain an ester of an aromatic acid, or an aromatic ketone. The compositions are readily implanted beneath a patient's body surface by injection, as the aromatic alcohol not only facilitates solubilization of the polymer, but also acts as a thixotropic agent, substantially increasing the shear thinning behavior of the composition.

    METHOD FOR CONTROLLING LIPOSOME SIZE
    83.
    发明授权
    METHOD FOR CONTROLLING LIPOSOME SIZE 有权
    控制程序脂质体SIZE

    公开(公告)号:EP1150658B1

    公开(公告)日:2004-08-04

    申请号:EP00907183.8

    申请日:2000-02-03

    申请人: Alza Corporation

    IPC分类号: A61K9/127 A61K9/133

    CPC分类号: A61K9/1277

    摘要: A method of preparing liposomes to a selected particle size is described. In the method, a vesicle-forming lipid dissolved in a lipid solvent is hydrated with a second solvent to form a hydration mixture having greater than 10 and less than 50 weight percent of the lipid solvent. The target amount of lipid solvent in the lipid solvent is selected to obtain a desired particle size.

    Novel formulations for the transdermal administration of fluoxetine
    85.
    发明公开
    Novel formulations for the transdermal administration of fluoxetine 失效
    Neue Formulierungen zur transdermale Verabreichung von Fluoxetin

    公开(公告)号:EP1393724A2

    公开(公告)日:2004-03-03

    申请号:EP03022248.3

    申请日:1997-07-15

    申请人: ALZA CORPORATION

    IPC分类号: A61K31/138 A61K9/70

    CPC分类号: A61K9/7084 A61K31/135

    摘要: A device for the transdermal administration of fluoxetine (10) at a therapeutically effective rate comprises:

    (a) a reservoir (12) containing a composition comprising an amount of a pharmaceutically acceptable salt of fluoxetine;
    (b) a backing (14) behind the body contacting-distal surface of the reservoir; and
    (c) means (16) for maintaining the reservoir in fluoxetine transmitting relation with a body surface or membrane.

    摘要翻译: 用于以治疗有效速率透皮施用氟西汀(10)的装置包括:(a)含有一定量的药物可接受的氟西汀盐的组合物的储存器(12) (b)在容器的身体接触远侧表面后面的背衬(14); 和(c)用于维持储存器与体表或膜的氟西汀传递关系的装置(16)。